{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T19:48:27Z","timestamp":1708372107591},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1983,12,1]],"date-time":"1983-12-01T00:00:00Z","timestamp":439084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1983,12,1]],"date-time":"1983-12-01T00:00:00Z","timestamp":439084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[1983,12]]},"DOI":"10.1007\/bf00177421","type":"journal-article","created":{"date-parts":[[2004,8,21]],"date-time":"2004-08-21T12:41:41Z","timestamp":1093092101000},"page":"349-353","source":"Crossref","is-referenced-by-count":6,"title":["Clinical evaluation of 4\u2032-epi-doxorubicin in advanced solid tumors"],"prefix":"10.1007","volume":"1","author":[{"given":"Gioacchino Robustelli Della","family":"Cuna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Pavesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piero","family":"Preti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrizio","family":"Ganzina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF00177421_CR1","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1056\/NEJM198107163050305","volume":"305","author":"RC Young","year":"1981","unstructured":"Young RC, Ozols RE, Myers CE: The anthracyclines antineoplastic drugs. N Engl J Med 305:139\u2013153, 1981","journal-title":"N Engl J Med"},{"key":"BF00177421_CR2","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1021\/jm00241a013","volume":"18","author":"F Arcamone","year":"1975","unstructured":"Arcamone F, Penco S, Vigevani A, Redaelli S, Franchi S, Di Marco A, Casazza AM, Dasdia T, Formelli F, Necco A, Soranzo C: Synthesis and antitumor properties of new glycosides of daunomycinone and adriamycinone. J Med Chem 18:703\u2013707, 1975","journal-title":"J Med Chem"},{"key":"BF00177421_CR3","unstructured":"Casazza AM, Di Marco A, Bertazzoli C, Formelli F, Giuliani F, Pratesi G: Antitumor activity, toxicity and pharmacological properties of 4\u2032-epiadriamycin. Current Chemotherapy. Proceedings of the 10th International Congress of Chemotherapy 2, 1978, pp 1257\u20131260"},{"key":"BF00177421_CR4","unstructured":"Casazza AM, Di Marco A, Bonadonna G, Bonfante V, Bertazzoli C, Bellini O, Pratesi G, Sala L, Ballernini L: Effects of modifications in position 4 of the chromophore or in position 4\u2032 of the aminosugar, on the antitumor activity and toxicity of daunorubicin and doxorubicin. In: Crooke ST, Reich SD (eds) Anthracyclines: Current Status and New Developments. Academic, Press, 1980, 23, pp 403\u2013429"},{"key":"BF00177421_CR5","first-page":"915","volume":"63","author":"V Bonfante","year":"1979","unstructured":"Bonfante V, Bonadonna G, Villani F, Di Fronzo G, Martini A, Casazza AM: Preliminary phase I study of 4\u2032-epiadriamycin. Cancer Treat Rep 63:915\u2013918, 1979","journal-title":"Cancer Treat Rep"},{"key":"BF00177421_CR6","first-page":"433","volume":"4","author":"PK Schauer","year":"1981","unstructured":"Schauer PK, Wittes RE, Gralla RJ, Casper ES, Young CW; A phase I trial of 4\u2032-epi-adriamycin. Cancer Clin Trials 4:433\u2013437, 1981","journal-title":"Cancer Clin Trials"},{"key":"BF00177421_CR7","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1177\/030089168206800202","volume":"68","author":"V Bonfante","year":"1982","unstructured":"Bonfante V, Villani F, Bonadonna G: Toxic and therapeutic activity of 4\u2032-epi-doxorubicin. Tumori 68:105\u2013111, 1982","journal-title":"Tumori"},{"key":"BF00177421_CR8","doi-asserted-by":"crossref","first-page":"249","DOI":"10.7326\/0003-4819-80-2-249","volume":"80","author":"RH Blum","year":"1974","unstructured":"Blum RH, Carter SK: Adriamycin, a new anticancer drug with significant clinical activity. Ann Intern Med 80:249\u2013259, 1974","journal-title":"Ann Intern Med"},{"key":"BF00177421_CR9","first-page":"231","volume":"6","author":"G Bonadonna","year":"1975","unstructured":"Bonadonna G, Beretta G, Tancini G, Brambilla C, Bajetta E, De Palo GM, De Lena M, Fossati Bellani F, Gasparini M, Valagussa P, Veronesi U: Adriamycin (NSC-123127) studies at the Istituto Nazionale Tumori, Milan. Cancer Chemother Rep (part 3) 6:231\u2013245, 1975","journal-title":"Cancer Chemother Rep (part 3)"},{"key":"BF00177421_CR10","first-page":"897","volume":"63","author":"M Broggini","year":"1980","unstructured":"Broggini M, Colombo T, Martini A, Donelli MG: Studies on the comparative distribution and biliary excretion of doxorubicin and 4\u2032-epi-doxorubicin in mice and rats. Cancer Treat Rep 63:897\u2013904, 1980","journal-title":"Cancer Treat Rep"},{"key":"BF00177421_CR11","unstructured":"Martini A, Isetta AM, Moro E, Natale N, Piazza E: Studio farmacocinetico nell'uomo sulla 4\u2032-epi-doxorubicina in confronto a doxorubicina. Tumori 6 (2), Suppl A, no 40, 1980 (Abstract)"},{"key":"BF00177421_CR12","first-page":"1819","volume":"66","author":"CM Camaggi","year":"1982","unstructured":"Camaggi CM, Strocchi E, Tamassia V, Martoni A, Giovannini M, Infelice C, Canova N, Marraro D, Martini A, Pannuti F: Pharmacokinetics studies of 4\u2032-epi-doxorubicin in cancer patients with normal and impaired renal function and with hepatic metastasis. Cancer Treat Rep 66:1819\u20131824, 1982","journal-title":"Cancer Treat Rep"},{"key":"BF00177421_CR13","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/BF00180192","volume":"1","author":"H Weenen","year":"1983","unstructured":"Weenen H, Lankelma J, Penders PGM, McWie JG, Ten Bokkel Huinink WW, de Planque MM, Pinedo HM: Pharmacokinetics of 4\u2032-epi-doxorubicin in man. Invest N Drugs 1:59\u201364, 1983","journal-title":"Invest N Drugs"},{"key":"BF00177421_CR14","doi-asserted-by":"crossref","first-page":"710","DOI":"10.7326\/0003-4819-91-5-710","volume":"91","author":"DD Von Hoff","year":"1979","unstructured":"Von Hoff DD, Layard MW, Basa P, Davis HL, Von Hoff AL, Rozencweig M, Muggia F: Risk factors for doxorubicin-induced congestive heart failure. Ann Intern Med 91:710\u2013717, 1979","journal-title":"Ann Intern Med"},{"key":"BF00177421_CR15","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1002\/1097-0142(197705)39:5<1940::AID-CNCR2820390505>3.0.CO;2-0","volume":"39","author":"RM O'Bryan","year":"1977","unstructured":"O'Bryan RM, Baker LH, Gottlieb JE, Rivkin SE, Balcerzak SP, Grumet GN, Salmon SE, Moon TE, Hoogstraten B: Dose response evaluation of adriamycin in human neoplasia. Cancer 39:1940\u20131948, 1977","journal-title":"Cancer"},{"key":"BF00177421_CR16","unstructured":"Young CW, Wittes RE, Jain K, Casper ES: Clinical evaluation of 4\u2032-epi-doxorubicin. 13th International Congress of Chemotherapy, Vienna (Austria), August 28th\u2013September 2nd, 1983"},{"key":"BF00177421_CR17","first-page":"109","volume":"2","author":"RE Wittes","year":"1983","unstructured":"Wittes RE, Jain K, Kaufman R, Currie V, Hakes T, Bosl G, Benedetto P, Young C: A randomized comparison of 4\u2032-epidoxorubicin (4\u2032-ED) and doxorubicin (DOX) in advanced breast cancer. Proc Am Soc Clin Oncol 2:109, 1983 (Abstract)","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF00177421_CR18","first-page":"1219","volume":"66","author":"SD Fossa","year":"1982","unstructured":"Fossa SD, Wik B, Bae E, Lien HN: Phase II study of 4\u2032-epidoxorubicin in metastatic renal cancer. Cancer Treat Rep 66:1219\u20131221, 1982","journal-title":"Cancer Treat Rep"},{"key":"BF00177421_CR19","doi-asserted-by":"crossref","unstructured":"Kolaric K, Potrebica V, Cervek Y: Phase II clinical trial of 4\u2032-epi-doxorubicin in metastatic solid tumors. J Cancer Res Clin Oncol 1983, (in press)","DOI":"10.1007\/BF00395394"},{"key":"BF00177421_CR20","doi-asserted-by":"crossref","unstructured":"Falkson G, Falkson HC, Vorobiof DA, Pretoriuss HL, Falkson CB: A phase Ii study of 4\u2032-epi-doxorubicin in colorectal cancer. 13th International Congress of Chemotheapy, Vienna (Austria), August 28th\u2013September 2nd, 1983","DOI":"10.1007\/BF00194597"},{"key":"BF00177421_CR21","first-page":"1462","volume":"2","author":"Della Cuna G Robustelli","year":"1982","unstructured":"Robustelli Della Cuna G, Pavesi L, Cuzzoni Q, Ganzina F, Tramarin R: A phase II study of 4\u2032-epi-adriamycin in advanced solid tumors. Curr Chemother Immunother 2:1462\u20131464, 1982","journal-title":"Curr Chemother Immunother"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00177421.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF00177421\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00177421","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00177421.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T18:26:26Z","timestamp":1678559186000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF00177421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1983,12]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1983,12]]}},"alternative-id":["BF00177421"],"URL":"https:\/\/doi.org\/10.1007\/bf00177421","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[1983,12]]}}}